138 related articles for article (PubMed ID: 11547604)
1. New long-acting insulin available.
Mayo Clin Health Lett; 2001 Sep; 19(9):4. PubMed ID: 11547604
[No Abstract] [Full Text] [Related]
2. [Are des-Phe-insulin-containing insulin combinations preferable to regular trade preparations?].
Sachse G; Federlin K
Med Klin; 1981 May; 76(11):319-23. PubMed ID: 7017364
[TBL] [Abstract][Full Text] [Related]
3. [Comparative efficacy of long-acting insulin preparations in diabetes mellitus].
Skrobonskaia NA; Lapko LI
Vrach Delo; 1969 Oct; 10():29-32. PubMed ID: 5366808
[No Abstract] [Full Text] [Related]
4. Insulin detemir, does a new century bring a better basal insulin?
Hordern SV; Russell-Jones DL
Int J Clin Pract; 2005 Jun; 59(6):730-9. PubMed ID: 15924603
[TBL] [Abstract][Full Text] [Related]
5. [Insulin therapy in diabetes mellitus].
Gambassi G
Minerva Med; 1976 Jan; 67(3):194-207. PubMed ID: 1250218
[No Abstract] [Full Text] [Related]
6. Insulin formulations--a review.
Gualandi-Signorini AM; Giorgi G
Eur Rev Med Pharmacol Sci; 2001; 5(3):73-83. PubMed ID: 12004916
[TBL] [Abstract][Full Text] [Related]
7. [Experience in the treatment of diabetes mellitus with delayed-action insulin preparations].
Piasetskiĭ NR; Tirkina TN; Danilova NS
Klin Med (Mosk); 1967 May; 45(5):22-8. PubMed ID: 5607519
[No Abstract] [Full Text] [Related]
8. [On new insulin preparations with prolonged action].
Preobrazhenskiĭ AP
Klin Med (Mosk); 1966 May; 44(5):3-7. PubMed ID: 5989394
[No Abstract] [Full Text] [Related]
9. [On experiences with deponal-insulin, a new depot insulin from VEB Berlin Chemie].
Bruns W; Jutzi E; Kirsch E; Mohnike G; Schliack V
Dtsch Gesundheitsw; 1966 Sep; 21(37):1733-5. PubMed ID: 5929209
[No Abstract] [Full Text] [Related]
10. A crystal clear solution for insulin delivery.
Merkle HP; Jen A
Nat Biotechnol; 2002 Aug; 20(8):789-90. PubMed ID: 12148005
[No Abstract] [Full Text] [Related]
11. Insulin kinetics.
Kapur A
J Assoc Physicians India; 1997; Suppl 1():13-7. PubMed ID: 11235628
[No Abstract] [Full Text] [Related]
12. Insulin analogues in the management of diabetes.
Vázquez-Carrera M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2004; 26(6):445-61. PubMed ID: 15349139
[TBL] [Abstract][Full Text] [Related]
13. [Experiences with a depot-body-free delayed-action insulin].
Schliack V; Lotz U
Munch Med Wochenschr; 1967 Jun; 109(24):1328-33. PubMed ID: 5631747
[No Abstract] [Full Text] [Related]
14. [Therapeutic experience with Rapitard insulin].
Fallucca F; Javicoli M
Policlinico Med; 1971; 78(4):182-93. PubMed ID: 4941980
[No Abstract] [Full Text] [Related]
15. An update on the long-acting insulin analogue glargine.
Thisted H; Johnsen SP; Rungby J
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
[TBL] [Abstract][Full Text] [Related]
16. [What's new in insulin treatment?].
Parhofer K
MMW Fortschr Med; 2004 Mar; 146(12):41-4. PubMed ID: 15357503
[No Abstract] [Full Text] [Related]
17. Insulin glargine (Lantus).
Owens DR; Griffiths S
Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
[TBL] [Abstract][Full Text] [Related]
18. [Insulin analogues: place of detemir (Levemir)].
Dorchy H; Sternon J
J Pharm Belg; 2006; 61(2):58-62. PubMed ID: 16866083
[TBL] [Abstract][Full Text] [Related]
19. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
[TBL] [Abstract][Full Text] [Related]
20. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
Peterson GE
Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
